Hexima was pleased to be featured at Edison Open House: Global Healthcare 2022. Edison Group is an investment research, investor relations and consulting firm with offices in North America, Europe, the Middle East and AsiaPac. It hosts Edison Open House: Global Healthcare, an event looking at the trends affecting global healthcare.
BBC journalist, Vivienne Parry OBE, spoke with Hexima’s CEO Michael Aldridge on Tuesday, 25 January 2022 (7PM AEDT), to discuss onychomycosis (fungal nail infection) and how Hexima’s lead product in development, pezadeftide, has the potential to be a safe, convenient, and effective solution in this large and underserved market.
Read the Edison research report here → Research Report
Or watch the interview here → Edison Interview
